MedPath

Balanced anaesthesia used in supratentorial craniotomy surgery

Not yet recruiting
Conditions
Diseases of the nervous system,
Registration Number
CTRI/2025/04/084227
Lead Sponsor
Dr Mohamed Anus Thoufeeque S
Brief Summary

Neuromuscular blocking agents have been one of the cornerstones of anaesthesia.

When balanced anaesthesia with desflurane,dexedetomidine,propofol infusion and scalp block will prelude the use of neuromuscular blocking agents in patients undergoing supratentorial craniotomy surgery under intense hemodynamic monitoring.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

American Society of Anaesthesiologists(ASA) physical status I & II, Glasgow Coma Score of 15, Undergoing elective craniotomy surgery for supratentorial lesions.

Exclusion Criteria

Refusal to consent, Known hypersensitivity to drugs being used, Pregnant and lactating patients, Sick sinus syndrome, Patients on beta blockers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To elicit the clinical effects and physiological parameters during the maintenance phase of anaesthesia in patients undergoing supratentorial craniotomy surgeryOutcomes will assessed during intraoperatively till the end of surgery and postoperatively for 1 hour.
Secondary Outcome Measures
NameTimeMethod
TO ASSESS THE TIME TAKEN FOR DISCHARGE FROM POST ANAESTHETIC CARE UNITPOSTOPERATIVE PERIOD
To assess the time taken for discharge from the post anaesthetic care unitPostoperatively for 1 hour

Trial Locations

Locations (1)

Institute of Anaesthesiology,Government Rajaji Hospital & Madurai Medical College,Madurai

🇮🇳

Madurai, TAMIL NADU, India

Institute of Anaesthesiology,Government Rajaji Hospital & Madurai Medical College,Madurai
🇮🇳Madurai, TAMIL NADU, India
Dr Mohamed Anus Thoufeeque S
Principal investigator
06380037643
thoufeeqcmc266@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.